HC Wainwright Initiates Stemline Therapeutics At Buy
April 27, 2015 at 09:31 AM EDT
In a report published Monday, H.C. Wainwright analysts initiated coverage of Stemline Therapeutics Inc (NASDAQ: STML) with a Buy rating ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.